Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
One year in: the government is making decent down payments for the years ahead
It’s fair to say it hasn’t been a straightforward first year for the government.Britons back local leaders with fiscal firepower
“Death and taxes,” they say, are life’s only certainties. But there’s a third - wherever taxes are controlled, power lies.Filling the funding gap: at what cost to Scotland’s public services?
Last week the Scottish government published its delayed Medium Term Financial Strategy (MTFS) which ‘provides the economic, funding and spending outlooks for the financial years 2025/26 to 2029/30’ and ‘the Government’s fiscal strategy to…